Business & Mission

CEMAG Care mission is to answer patients’ medical needs by developing and commercializing innovative medical devices and drugs by allowing access of these treatments to populations in need.

To achieve this mission, we foster innovative healthcare research projects into viable commercial products (drugs, medtech, biotech) and bring them to patients. Our motivation is to answer meaningful unmet medical needs and bring to all patients the care they deserve.

Test Covid-19 combiné à l'application IDA One

Fort de son expérience dans le domaine du dispositif médical de diagnostic in-vitro et de sa structure d’établissement pharmaceutique, CEMAG Care distribue le test de détection COVID-19 anticorps IgM/IgG du laboratoire canadien Artron Laboratories Inc.

Pour toute commande (Bon de commande) ou demande de renseignement, vous pouvez nous contacter par téléphone au 01 58 28 16 83 ou par mail à l’adresse suivante : serviceclient@cemagcare.com 

Pharma-ope-blue

PHARMACEUTICAL OPERATIONS

Supplying diverse drugs to the European market

READ MORE
Innov-Medic-Device-blue

INNOVATIVE MEDICAL DEVICES

Development and commercialization of healthcare innovation:

Fostering the development and the commercialization of healthcare innovations such as medical devices or in vitro diagnostics

READ MORE
Non-For-Profit-blue

NON-FOR-PROFIT

Specific activity toward Non-For-Profit Organizations to facilitate medical product accessibility to population in need

READ MORE

PHARMACEUTICAL OPERATIONS

Pharmaceutical operations of various pharmaceutical products in France (“Exploitant Pharmaceutique”, MAH) and other European countries:

> Market Authorization Holder and distribution of pharmaceutical products

> Regulatory (submissions, applications and regulatory Life Cycle Management activities….)

> Medical Affairs (pharmacovigilance, medical information, clinical studies, scientific advice, Literature reviews, medical writing…)

> Service activities for third parties for regulatory strategy and registration in Europe

> A senior team with high expertise and a history of success stories

> Exploitant of Marketing Authorisations in France

In compliance with article L.5121-1-3 of French Public Health Code (Code de la Santé Publique), please find below the list of all active substances of drug products exploited by Cemag Care :

LIST OF DRUG PRODUCTS EXPLOITED BY CEMAG CARE

For medical information request or pharmacovigilance, please contact pharmacovigilance@cemagcare.com

 

Et le tri ?

 

Découvrez toutes les consignes de tri et les lieux de collecte près de chez vous sur www.consignesdetri.fr.

INNOVATIVE MEDICAL DEVICES

> Product development in accordance with ISO13485: from initial patient needs to breakthrough medical solutions.

> Fostering our own projects of medical devices

> Providing service activities to help the development of innovative medical solutions (from Proof of Concept Studies to Market authorization

> Materiovigilance

> An expertized team focused on innovation for patients

NON-FOR-PROFIT

In healthcare, all patients are entitled to all approved products with the highest quality standards.

> Facilitating relationship between For-Profit Healthcare industry and Non-For-Profit Organizations, to allow :

          > Populations in needs to access healthcare products
          > Healthcare companies to develop new markets and increase their product volumes

> Supplier for Pharma industries dedicated to Non-For-Profit and Public markets (handling of tenders, agreements, logistics)

> Strong network with Non-For-Profit Organizations

our assets

Who we are

AREAS WHERE WE ARE CURRENTLY ACTIVE

Dermatology & Wound care

> Women’s health (innovative fertility regulation methods)

> Diagnostics

 

 

> Emergency healthcare (e.g. bioterrorism)

> Orphan diseases

> Addiction

OUR NEWS


CEMAG Care & COVID-19 serological test

CEMAG Care & COVID-19 serological test

May 2020

Due to the increasing need for reliable detection tests of covid19 infection, CEMAG Care is working on distributing a CE-mark rapid test detecting SARS-CoV-2 IgG/IgM antibodies which will be available in the coming weeks.

COVID

Cemag Care is MAH

Cemag Care is MAH

March 2019

Cemag Care is MAH of CURETHYL 26 POUR CENT, solution injectable I.V, CALPRIMUM 500 mg, comprimé enrobé à croquer, and ASCOFER 33 mg, gélule

MAH

sme status

SME STATUS

December 2018

CEMAG Care is requalified as an SME by the EMA (SME Office).

news-sme

ANDRÉ ULMANN’S BOOK

ANDRÉ ULMANN'S BOOK

March 2017

André Ulmann’s book « Le combat d’un médecin pour les femmes » has just been published (French edition only for the moment).

9791031202143